For example, under the Accelerating Medicines Partnership, the NIH and ten biopharmaceutical companies will fund a five-year effort to validate promising targets in three disease areas. Other initiatives include efforts in Alzheimer’s research to test competing drugs against one shared “placebo arm” in clinical trials, and in cancer research to test multiple therapies in a single trial and identify the most responsive patients.
在看不见万灵丹的情况下，一些其他办法正在获得关注。为了实现投资最大化，公私部门正在日益集中资源。比如，在医学合作出金计划（Accelerating Medicines Partnership）中，NIH和十家生物制药公司将为一个五年计划提供资金，旨在在三种疾病领域实现承诺目标。其他项目包括在阿尔兹海默症研究中检测不同药品在临床试验中对同一“安慰剂”的对比效果，以及在癌症研究的单一试验中测试多种疗法和识别反应最强的患者。